Print

Purpose

This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of any pancreatic pre-malignant lesion and/or pancreatic malignancy - Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically

Exclusion Criteria

  • Patients with co-existing malignancies of other organs (or a prior history of such) - Patients unable to provide informed consent - Patients unable to complete follow-up

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Case-Only
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Adult patients who undergo EUS-RFA for treatment of pancreatic lesions
  • Device: Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)
    EUS-guided Radiofrequency Ablation (RFA) consists of the application of alternating current with a frequency of 350-500 kHz (coincidentally the frequency range of radio broadcasts as well) to the target tissue via a special electrode located at the tip of the endoscope.

Recruiting Locations

The University of Texas Health Science Center at Houston
Houston, Texas 77030
Contact:
Amatullah Alibhai, MBA
713-500-6658
Amatullah.Alibhai@uth.tmc.edu

More Details

Status
Recruiting
Sponsor
The University of Texas Health Science Center, Houston

Study Contact

Amatullah Alibhai, MBA
713-500-6658
Amatullah.Alibhai@uth.tmc.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.